Vimab Group AB (publ) (STO:VIMAB)
Sweden · Delayed Price · Currency is SEK 2.580
+0.070 (2.79%)
At close: Feb 5, 2026
Vimab Group AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 315.14 | 325.29 | 342.35 | 227.29 | 205.68 | 216.85 |
Other Revenue | - | - | - | - | - | -0 |
| 315.14 | 325.29 | 342.35 | 227.29 | 205.68 | 216.85 | |
Revenue Growth (YoY) | -10.77% | -4.98% | 50.63% | 10.51% | -5.15% | - |
Cost of Revenue | 256.81 | 245.27 | 233.02 | 164.35 | 157.04 | 175.3 |
Gross Profit | 58.34 | 80.02 | 109.33 | 62.94 | 48.64 | 41.55 |
Selling, General & Admin | 85.84 | 97.4 | 83.56 | 57.41 | 56.02 | 44.81 |
Other Operating Expenses | -0.81 | -1.09 | -1.09 | -1.08 | -2.89 | -8.07 |
Operating Expenses | 141.21 | 159.51 | 107.65 | 77.11 | 70 | 60.38 |
Operating Income | -82.87 | -79.49 | 1.69 | -14.17 | -21.35 | -18.84 |
Interest Expense | -20.04 | -7.47 | -9.2 | -2.44 | -4.82 | -18.68 |
Interest & Investment Income | 0.12 | 0.12 | 3.98 | 0.08 | 3.9 | 6.12 |
Earnings From Equity Investments | - | - | -7.01 | - | - | - |
Currency Exchange Gain (Loss) | 1.82 | 1.82 | 1.93 | 0.46 | - | - |
Other Non Operating Income (Expenses) | 2.71 | -1.28 | 0.3 | - | - | 0 |
EBT Excluding Unusual Items | -98.27 | -86.29 | -8.31 | -16.07 | -22.27 | -31.39 |
Gain (Loss) on Sale of Investments | -0.03 | -0.03 | - | - | -2.49 | -14.7 |
Gain (Loss) on Sale of Assets | 0.74 | 0.74 | 3.06 | - | 0.12 | - |
Other Unusual Items | - | - | - | -15.75 | - | - |
Pretax Income | -97.56 | -85.58 | -5.25 | -31.82 | -24.64 | -46.09 |
Income Tax Expense | -0.88 | -0.76 | 1.16 | 2.4 | -0.56 | 0.19 |
Earnings From Continuing Operations | -96.68 | -84.82 | -6.41 | -34.22 | -24.09 | -46.29 |
Minority Interest in Earnings | 5.82 | 7.88 | 2.15 | - | - | - |
Net Income | -90.86 | -76.94 | -4.26 | -34.22 | -24.09 | -46.29 |
Net Income to Common | -90.86 | -76.94 | -4.26 | -34.22 | -24.09 | -46.29 |
Shares Outstanding (Basic) | 25 | 23 | 21 | 10 | 3 | - |
Shares Outstanding (Diluted) | 25 | 23 | 21 | 10 | 3 | - |
Shares Change (YoY) | 11.33% | 10.99% | 110.97% | 265.91% | - | - |
EPS (Basic) | -3.57 | -3.31 | -0.20 | -3.44 | -8.87 | - |
EPS (Diluted) | -3.57 | -3.31 | -0.20 | -3.44 | -8.87 | - |
Free Cash Flow | -44.39 | -0.58 | 6.4 | 1.21 | -8.58 | -4.35 |
Free Cash Flow Per Share | -1.75 | -0.03 | 0.30 | 0.12 | -3.16 | - |
Gross Margin | 18.51% | 24.60% | 31.94% | 27.69% | 23.65% | 19.16% |
Operating Margin | -26.30% | -24.44% | 0.49% | -6.23% | -10.38% | -8.69% |
Profit Margin | -28.83% | -23.65% | -1.24% | -15.06% | -11.71% | -21.34% |
Free Cash Flow Margin | -14.09% | -0.18% | 1.87% | 0.53% | -4.17% | -2.00% |
EBITDA | -26.72 | -16.31 | 26.86 | 5.62 | -3.17 | 4.8 |
EBITDA Margin | -8.48% | -5.01% | 7.85% | 2.47% | -1.54% | 2.21% |
D&A For EBITDA | 56.16 | 63.18 | 25.18 | 19.78 | 18.19 | 23.64 |
EBIT | -82.87 | -79.49 | 1.69 | -14.17 | -21.35 | -18.84 |
EBIT Margin | -26.30% | -24.44% | 0.49% | -6.23% | -10.38% | -8.69% |
Revenue as Reported | 324.09 | 330.25 | 347.82 | 229.25 | 209.04 | 226.43 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.